IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
JHS Svendgaard Laboratories IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 35.96 Cr. The company is based in Sirmour and caters to Healthcare sector. Centrum Capital , Uti Securities are the merchant bankers of JHS Svendgaard Laboratories IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 30th November -0001.
JHS Svendgaard Laboratories IPO posted revenues of ₹ 30.04 Cr. and PAT of ₹ 4.03 Cr. in FY25 on annualised basis.
Revenue:
₹ 30.04 Cr.
EBITDA Margin:
18.74
% 
Net Worth: ₹ 13.60 Cr.
Market Capitalisation:
[●]
P/E:
5.85 times
P/BV: [●]
EV/EBITDA: 1.26 times
Financial results of JHS Svendgaard Laboratories IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY06 | ||||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 27.24 | ||||
| Net Worth | 13.60 | ||||
| Total Debt | 7.66 | ||||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
30.04 | ||||
EBITDA
EBITDA on annualised basis |
5.63 | ||||
PAT
PAT on annualised basis |
4.03 | ||||
JHS Svendgaard Laboratories IPO PAT Margin is 13.42 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows JHS Svendgaard Laboratories IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY06 |
|---|---|
| EBITDA Margin (%) | 18.74 |
| PAT Margin (%) | 13.42 |
| EPS (₹) | 9.92 |
| ROE (%) | 29.63 |
| ROCE (%) | [●] |
| ROA (%) | 14.79 |
| Debt to Equity | 0.56 |
The market Capitalisation of JHS Svendgaard Laboratories IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The JHS Svendgaard Laboratories IPO prospectus highlights an Return on Equity (ROE) of 29.63 % , Return on Assets (ROA) of 14.79 %, and an EBITDA Margin of 18.74 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows JHS Svendgaard Laboratories IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of JHS Svendgaard Laboratories IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The JHS Svendgaard Laboratories IPO has a Price-to-Earnings (PE) ratio of 5.85 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
JHS Svendgaard Laboratories IPO reported revenue of ₹ 0.00 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from JHS Svendgaard Laboratories IPO provide insights into sales growth, market demand, and business scalability.
JHS Svendgaard Laboratories recorded an EBITDA of ₹ 5.63 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
JHS Svendgaard Laboratories Profit After Tax (PAT) is ₹ 4.03 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 30.04 Cr.
EBITDA Margin:
18.74
%
Net Worth: ₹ 13.60 Cr.
Market Capitalisation:
[●]
P/E:
5.85 times
P/BV: [●]
EV/EBITDA:
[●]
JHS Svendgaard Laboratories operates in Healthcare and Dental And Oral Healthcare Products. The Issue is listed on BSE,NSE in Oct, 2006. JHS Svendgaard Laboratories IPO size was 35.96 with Issue price of 58.00 .
Merchant Banker(s) of JHS Svendgaard Laboratories IPO: Centrum Capital Limited , Uti Securities Limited
JHS Svendgaard Laboratories IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
JHS Svendgaard Laboratories IPO listed at a listing price of 57.05 against the offer price of 58.00.
The current market price of JHS Svendgaard Laboratories is 11.40.
Why Us?
